Advanced search
Show most relevant results first | Most recent results are first | Show use by person

Search only Louise O'ReillySearch all speeches

Results 8,261-8,280 of 12,773 for speaker:Louise O'Reilly

Joint Oireachtas Committee on Health: National Medicines Strategy: Discussion (6 Mar 2019)

Louise O'Reilly: Is there anything we can do to improve on it?

Joint Oireachtas Committee on Health: National Medicines Strategy: Discussion (6 Mar 2019)

Louise O'Reilly: Therefore the industry is effectively policing itself in this regard.

Joint Oireachtas Committee on Health: National Medicines Strategy: Discussion (6 Mar 2019)

Louise O'Reilly: I do not know how true it is but we have all read that most global pharmaceutical companies will spend more on advertising than on research and development. If that is the case, it undermines much of the discourse on the subject. These debates get very heated because we are talking about seriously ill people and, in some instances, seriously ill children. The retort from the pharmaceutical...

Joint Oireachtas Committee on Health: National Medicines Strategy: Discussion (6 Mar 2019)

Louise O'Reilly: Do the witnesses imagine that it goes on advertising?

Joint Oireachtas Committee on Health: National Medicines Strategy: Discussion (6 Mar 2019)

Louise O'Reilly: Is a good chunk of the money spent on advertising?

Joint Oireachtas Committee on Health: National Medicines Strategy: Discussion (6 Mar 2019)

Louise O'Reilly: I thank the witnesses.

Joint Oireachtas Committee on Health: National Medicines Strategy: Discussion (6 Mar 2019)

Louise O'Reilly: It is interesting that Dr. Harkin would hold out the hope for BeNeLuxA because it is important that it would deliver. Outside our roles as Deputies or Senators, is there anything practical that we as a committee can do in response to the issues he raised? We may not all agree on everything and there are people here who have a much more benign view of pharmaceutical companies than I do but...

Joint Oireachtas Committee on Health: National Medicines Strategy: Discussion (6 Mar 2019)

Louise O'Reilly: Or if we could attach a proviso that further public investment is on the basis of a return for public health. That should not be a wild or strange concept but perhaps it is. We should consider that.

Joint Oireachtas Committee on Health: National Medicines Strategy: Discussion (6 Mar 2019)

Louise O'Reilly: It is hard to define exactly what the investment is because if the laboratory has been built and staffed and a company sponsors a bursary of €30,000 or €40,000 that investment is on paper but the State has invested in the bricks and mortar, the personnel, the person who comes to clean the place, and the lights. It is difficult to do but it is not impossible and it is not...

Withdrawal of the United Kingdom from the European Union (Consequential Provisions) Bill 2019: Committee Stage (5 Mar 2019)

Louise O'Reilly: I move amendment No. 23: In page 12, line 24, to delete “75C. An authorised officer” and substitute “75D. An authorised officer”.

Withdrawal of the United Kingdom from the European Union (Consequential Provisions) Bill 2019: Committee Stage (5 Mar 2019)

Louise O'Reilly: I move amendment No. 24: In page 12, line 36, to delete “75D. Every order” and substitute “75E. Every order”.

Withdrawal of the United Kingdom from the European Union (Consequential Provisions) Bill 2019: Committee Stage (5 Mar 2019)

Louise O'Reilly: The Minister says he agrees in principle with what I am saying because, clearly, it makes sense. However, he said that at the opportune time he would provide the report. I would be most grateful if he could firm up that proposal. We are saying within a year because, in the event that we have to enact this legislation, we are going to be in uncharted territory. It would be no harm, after...

Withdrawal of the United Kingdom from the European Union (Consequential Provisions) Bill 2019: Committee Stage (5 Mar 2019)

Louise O'Reilly: I move amendment No. 22:In page 12, between lines 22 and 23, to insert the following:"Review of the effectiveness of health services 75C.The Minister shall publish a review into the effectiveness of the health services covered under section 75A and 75B of this Act one year after the United Kingdom has left the European Union.". This is a straightforward amendment. Obviously, none of us...

Written Answers — Department of Public Expenditure and Reform: Information and Communications Technology (5 Mar 2019)

Louise O'Reilly: 155. To ask the Minister for Public Expenditure and Reform if Ireland has set up its electronic data exchange system known as e-cohesion; and if not, the reason. [10535/19]

Written Answers — Department of Public Expenditure and Reform: Information and Communications Technology (5 Mar 2019)

Louise O'Reilly: 156. To ask the Minister for Public Expenditure and Reform if Ireland has implemented a national information technology system to meet the 2014-2020 European Structural and Investment Funds requirements; and if not, the amount of funding which has either been lost or been unable to be drawn down each year due to this in tabular form. [10537/19]

Written Answers — Department of Public Expenditure and Reform: Information and Communications Technology (5 Mar 2019)

Louise O'Reilly: 157. To ask the Minister for Public Expenditure and Reform if Ireland has implemented a national information technology system to meet the 2014-2020 European Structural and Investment Funds requirements; and if not, the reason therefor. [10539/19]

Written Answers — Department of Public Expenditure and Reform: Information and Communications Technology (5 Mar 2019)

Louise O'Reilly: 158. To ask the Minister for Public Expenditure and Reform the estimated conclusion date for the implementation of a national information technology system to meet the 2014-2020 European Structural and Investment Funds requirements. [10541/19]

Written Answers — Department of Public Expenditure and Reform: Information and Communications Technology (5 Mar 2019)

Louise O'Reilly: 159. To ask the Minister for Public Expenditure and Reform the name of the company which won the tender for the contract to develop and implement the national information technology system to meet the 2014-2020 European Structural and Investment Funds requirements. [10543/19]

Written Answers — Department of Education and Skills: EU Funding (5 Mar 2019)

Louise O'Reilly: 194. To ask the Minister for Education and Skills further to Parliamentary Question No. 267 of 4 May 2016, if the structures and systems necessary to certify expenditure under the European Union regulations and have them verified by a designated body to a level acceptable to the European Commission in order to draw down youth employment initiative funding were ever implemented; if not, the...

Written Answers — Department of Health: Hospitals Building Programme (5 Mar 2019)

Louise O'Reilly: 277. To ask the Minister for Health the status of the provision of a new-build emergency department and surgical block with 147 single rooms at Sligo University Hospital. [10338/19]

   Advanced search
Show most relevant results first | Most recent results are first | Show use by person

Search only Louise O'ReillySearch all speeches